Drug search by name

Lutetium lu 177 dotatate Intravenous and Myelosuppression

Result of checking the interaction of drug Lutetium lu 177 dotatate Intravenous and disease Myelosuppression for safety when used together.

Check result:

Lutetium lu 177 dotatate Intravenous <> Myelosuppression

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

The use of lutetium Lu 177 dotatate may increase the risk of developing myelosuppression. Care should be exercised when using this agent in immunocompromised patients. It is recommended to monitor blood cell counts. Withhold, reduce dose, or permanently discontinue based on severity of adverse reaction.

Lutetium lu 177 dotatate Intravenous

Generic Name: lutetium lu 177 dotatate

Brand Name: Lutathera

Synonyms: Lutetium Lu 177 dotatate, Lutetium Lu 177 Dotatate

What is Lutetium lu 177 dotatate Intravenous?